Therefore, our results give additional evidence that TBR1 alterations play also a role in human cancers, in particular when considering that 11 out 12 cancer models representing the 3 urological tumor entities of kidney, urothelial, and prostate cancer show high TBR1 methylation. This evidence concerns the gene TBR1 and prostate cancer.